معرفی
Dr. Joel Saltz is a distinguished academic and clinician, holding the title of Cherith Professor and Founding Chair of the Department of Biomedical Informatics at Stony Brook University, housed dually in the School of Medicine and College of Engineering and Applied Sciences. He also serves as Vice President for Clinical Informatics at Stony Brook Medicine and Associate Director of the Stony Brook Cancer Center. His roles include Vice Chair for Laboratory Initiatives and Digital Medicine in the Department of Pathology. Dr. Saltz earned his MD and PhD in Computer Science through Duke University's Medical Scientist Training Program, followed by a residency in clinical pathology at Johns Hopkins University. He previously held faculty positions at Yale University, the University of Maryland, and founded biomedical informatics departments at Emory and Ohio State universities.
His research focuses on advancing digital pathology, AI-driven medical imaging, and high-performance computing. Key areas include tumor-infiltrating lymphocyte (TIL) mapping, computational pathology tools (e.g., the Virtual Microscope), and big data frameworks like DataCutter. He pioneered spatial analysis of cancer biomarkers and has contributed to map-reduce computing systems. His work integrates machine learning, database design, and high-end computing to address challenges in pathology and oncology.
Dr. Saltz leads initiatives such as the Center for Engineering Driven Medicine and co-leads the IBES Cancer Center program. His over 70 grants and 18,000+ citations highlight his impact in biomedical informatics. Collaborations with et al. include the Digital Pathology group at Stony Brook, developing AI tools for histopathology analysis. His educational contributions span courses in data analytics, high-performance computing, and biomedical informatics.
His awards include Fellow of the American College of Medical Informatics and the Cherith Chair. Notable achievements include founding three biomedical informatics departments and establishing foundational technologies in digital pathology. Current projects leverage AI and spatial analysis to improve cancer diagnosis and treatment prediction.
